{"url_path":"/sec/abbv/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1551152/0001551152-26-000017-index.html","accession_number":"0001551152-26-000017","cik":"0001551152","ticker":"ABBV","issuer_name":"AbbVie Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1551152/0001551152-26-000017-index.html","primary_entity_key":"0001551152","primary_entity_name":"AbbVie Inc."},"word_count":521,"has_tables":true,"body_markdown":"abbv-20260331\n0001551152falseDecember 312026Q1http://fasb.org/us-gaap/2025#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2025#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2025#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2025#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2025#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2025#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2025#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2025#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2025#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2025#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2025#MoneyMarketFundsMemberhttp://fasb.org/us-gaap/2025#Revenueshttp://fasb.org/us-gaap/2025#Revenueshttp://fasb.org/us-gaap/2025#Revenueshttp://fasb.org/us-gaap/2025#Revenues1xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureiso4217:EURiso4217:SEKiso4217:CADiso4217:CHFabbv:wholesalerabbv:lawsuitabbv:claimabbv:companyabbv:claimsabbv:segment00015511522026-01-012026-03-310001551152us-gaap:CommonStockMemberexch:XNYS2026-01-012026-03-310001551152abbv:Sec0.750SeniorNotesDue2027Memberexch:XNYS2026-01-012026-03-310001551152abbv:Sec2.125SeniorNotesdue2028Memberexch:XNYS2026-01-012026-03-310001551152abbv:Sec2625SeniorNotesDue2028Memberexch:XNYS2026-01-012026-03-310001551152abbv:Sec2125SeniorNotesDue2029Memberexch:XNYS2026-01-012026-03-310001551152abbv:Sec1.250SeniorNotesdue2031Memberexch:XNYS2026-01-012026-03-3100015511522026-04-2800015511522025-01-012025-03-3100015511522026-03-3100015511522025-12-310001551152us-gaap:CommonStockMember2024-12-310001551152us-gaap:TreasuryStockCommonMember2024-12-310001551152us-gaap:AdditionalPaidInCapitalMember2024-12-310001551152us-gaap:RetainedEarningsMember2024-12-310001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001551152us-gaap:NoncontrollingInterestMember2024-12-3100015511522024-12-310001551152us-gaap:CommonStockMember2025-01-012025-03-310001551152us-gaap:TreasuryStockCommonMember2025-01-012025-03-310001551152us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001551152us-gaap:RetainedEarningsMember2025-01-012025-03-310001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001551152us-gaap:NoncontrollingInterestMember2025-01-012025-03-310001551152us-gaap:CommonStockMember2025-03-310001551152us-gaap:TreasuryStockCommonMember2025-03-310001551152us-gaap:AdditionalPaidInCapitalMember2025-03-310001551152us-gaap:RetainedEarningsMember2025-03-310001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001551152us-gaap:NoncontrollingInterestMember2025-03-3100015511522025-03-310001551152us-gaap:CommonStockMember2025-12-310001551152us-gaap:TreasuryStockCommonMember2025-12-310001551152us-gaap:AdditionalPaidInCapitalMember2025-12-310001551152us-gaap:RetainedEarningsMember2025-12-310001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001551152us-gaap:NoncontrollingInterestMember2025-12-310001551152us-gaap:CommonStockMember2026-01-012026-03-310001551152us-gaap:TreasuryStockCommonMember2026-01-012026-03-310001551152us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310001551152us-gaap:RetainedEarningsMember2026-01-012026-03-310001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310001551152us-gaap:NoncontrollingInterestMember2026-01-012026-03-310001551152us-gaap:CommonStockMember2026-03-310001551152us-gaap:TreasuryStockCommonMember2026-03-310001551152us-gaap:AdditionalPaidInCapitalMember2026-03-310001551152us-gaap:RetainedEarningsMember2026-03-310001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310001551152us-gaap:NoncontrollingInterestMember2026-03-310001551152abbv:NimbleTherapeuticsInc.Member2026-01-012026-03-310001551152abbv:NimbleTherapeuticsInc.Member2025-01-230001551152abbv:OtherCollaborationArrangementsMemberus-gaap:CollaborativeArrangementMember2026-01-012026-03-310001551152abbv:OtherCollaborationArrangementsMemberus-gaap:CollaborativeArrangementMember2025-01-012025-03-310001551152us-gaap:CollaborativeArrangementMember2026-01-012026-03-310001551152us-gaap:CollaborativeArrangementMember2025-01-012025-03-310001551152abbv:RemeGenMember2026-01-012026-03-310001551152abbv:RemeGenMemberus-gaap:CollaborativeArrangementMember2026-03-310001551152abbv:GenentechInc.Memberus-gaap:CollaborativeArrangementMember2026-01-012026-03-310001551152abbv:GenentechInc.Memberus-gaap:CollaborativeArrangementMember2025-01-012025-03-310001551152abbv:JanssenBiotechIncMemberus-gaap:CollaborativeArrangementMember2026-01-012026-03-310001551152country:USus-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMember2026-01-012026-03-310001551152country:USus-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMember2025-01-012025-03-310001551152us-gaap:NonUsMemberus-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMember2026-01-012026-03-310001551152us-gaap:NonUsMemberus-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMember2025-01-012025-03-310001551152us-gaap:DevelopedTechnologyRightsMember2026-03-310001551152us-gaap:DevelopedTechnologyRightsMember2025-12-310001551152us-gaap:LicensingAgreementsMember2026-03-310001551152us-gaap:LicensingAgreementsMember2025-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-01-012026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2025-12-310001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:SeniorNotesMember2026-03-310001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:SeniorNotesMember2025-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-12-310001551152us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2026-03-310001551152us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2025-12-310001551152us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2025-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:NondesignatedMember2026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:NondesignatedMember2025-12-310001551152us-gaap:InterestRateSwapMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2026-03-310001551152us-gaap:InterestRateSwapMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2025-12-310001551152us-gaap:InterestRateSwapMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2026-03-310001551152us-gaap:InterestRateSwapMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2025-12-310001551152us-gaap:InterestRateSwapMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2026-03-310001551152us-gaap:InterestRateSwapMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2025-12-310001551152us-gaap:InterestRateSwapMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2026-03-310001551152us-gaap:InterestRateSwapMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2025-12-310001551152us-gaap:InterestRateSwapMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-03-310001551152us-gaap:InterestRateSwapMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-12-310001551152us-gaap:InterestRateSwapMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-03-310001551152us-gaap:InterestRateSwapMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2026-01-012026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-01-012025-03-310001551152us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2026-01-012026-03-310001551152us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-01-012025-03-310001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SeniorNotesMember2026-01-012026-03-310001551152us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SeniorNotesMember2025-01-012025-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-01-012025-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2026-01-012026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-01-012025-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2025-01-012025-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2026-01-012026-03-310001551152us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2025-01-012025-03-310001551152us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2026-01-012026-03-310001551152us-gaap:FairValueHedgingMemberus-gaap:InterestExpenseMember2026-01-012026-03-310001551152us-gaap:FairValueHedgingMemberus-gaap:InterestExpenseMember2025-01-012025-03-310001551152us-gaap:TreasuryLockMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-01-012026-03-310001551152us-gaap:TreasuryLockMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-01-012025-03-310001551152us-gaap:FairValueMeasurementsRecurringMember2026-03-310001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2026-03-310001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2026-03-310001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2026-03-310001551152us-gaap:FairValueMeasurementsRecurringMember2025-12-310001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-12-310001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-12-310001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-12-310001551152us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2026-03-310001551152us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2026-03-310001551152us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2026-03-310001551152us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2026-03-310001551152us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001551152us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-12-310001551152us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-12-310001551152us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-12-310001551152srt:MinimumMemberus-gaap:MeasurementInputDiscountRateMember2026-03-310001551152srt:MaximumMemberus-gaap:MeasurementInputDiscountRateMember2026-03-310001551152srt:WeightedAverageMemberus-gaap:MeasurementInputDiscountRateMember2026-03-310001551152srt:MaximumMemberus-gaap:MeasurementInputDiscountRateMember2025-12-310001551152srt:MinimumMemberus-gaap:MeasurementInputDiscountRateMember2025-12-310001551152srt:WeightedAverageMemberus-gaap:MeasurementInputDiscountRateMember2025-12-310001551152srt:MaximumMemberabbv:ProbabilityofPaymentforRoyaltiesbyIndicationMember2026-03-310001551152srt:WeightedAverageMemberabbv:ProbabilityofPaymentforRoyaltiesbyIndicationMember2026-03-310001551152srt:MaximumMemberabbv:ProbabilityofPaymentforRoyaltiesbyIndicationMember2025-12-310001551152srt:WeightedAverageMemberabbv:ProbabilityofPaymentforRoyaltiesbyIndicationMember2025-12-310001551152srt:MinimumMemberabbv:ProjectedYearofPaymentsMember2026-03-310001551152srt:MaximumMemberabbv:ProjectedYearofPaymentsMember2026-03-310001551152srt:WeightedAverageMemberabbv:ProjectedYearofPaymentsMember2026-03-310001551152srt:MinimumMemberabbv:ProjectedYearofPaymentsMember2025-12-310001551152srt:MaximumMemberabbv:ProjectedYearofPaymentsMember2025-12-310001551152srt:WeightedAverageMemberabbv:ProjectedYearofPaymentsMember2025-12-310001551152us-gaap:CarryingReportedAmountFairValueDisclosureMember2026-03-310001551152us-gaap:EstimateOfFairValueFairValueDisclosureMember2026-03-310001551152us-gaap:FairValueInputsLevel1Member2026-03-310001551152us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2026-03-310001551152us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2026-03-310001551152us-gaap:CarryingReportedAmountFairValueDisclosureMember2025-12-310001551152us-gaap:EstimateOfFairValueFairValueDisclosureMember2025-12-310001551152us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2025-12-310001551152us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2025-12-310001551152us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2025-12-310001551152us-gaap:FairValueInputsLevel1Member2025-12-310001551152us-gaap:AccountsReceivableMember2026-01-012026-03-310001551152us-gaap:AccountsReceivableMember2025-01-012025-12-310001551152abbv:PrincipalUSCustomersMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:AccountsReceivableMember2026-01-012026-03-310001551152abbv:PrincipalUSCustomersMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:AccountsReceivableMember2025-01-012025-12-310001551152abbv:SeniorNotesIssuedIn2026Memberus-gaap:SeniorNotesMember2026-03-310001551152abbv:FloatingRateSeniorNotesDue2028Memberus-gaap:SeniorNotesMember2026-03-310001551152abbv:A3.775SeniorNotesDue2028Memberus-gaap:SeniorNotesMember2026-03-310001551152abbv:A4.125SeniorNotesDue2031Memberus-gaap:SeniorNotesMember2026-03-310001551152abbv:A4.40SeniorNotesDue2033Memberus-gaap:SeniorNotesMember2026-03-310001551152abbv:A4.75SeniorNotesDue2036Memberus-gaap:SeniorNotesMember2026-03-310001551152abbv:A5.55SeniorNotesDue2056Memberus-gaap:SeniorNotesMember2026-03-310001551152abbv:A5.65SeniorNotesDue2066Memberus-gaap:SeniorNotesMember2026-03-310001551152abbv:SeniorNotesIssuedIn2026Member2026-01-012026-03-310001551152abbv:SeniorNotesIssuedIn2025Memberus-gaap:SeniorNotesMember2025-03-310001551152abbv:A3.80SeniorNotesMemberus-gaap:LoansPayableMember2025-01-012025-03-310001551152abbv:A3.80SeniorNotesMemberus-gaap:SeniorNotesMember2025-03-310001551152us-gaap:CommercialPaperMember2026-03-310001551152us-gaap:CommercialPaperMember2025-12-310001551152us-gaap:CommercialPaperMember2026-01-012026-03-310001551152us-gaap:CommercialPaperMember2025-01-012025-03-310001551152abbv:A364DayTermLoanCreditAgreementMember2026-03-310001551152abbv:A364DayTermLoanCreditAgreementMember2025-12-310001551152abbv:A364DayTermLoanCreditAgreementMember2026-01-012026-03-310001551152abbv:RevolvingCreditFacilityMaturing2028Member2026-03-310001551152abbv:RevolvingCreditFacilityMaturing2030Member2026-03-310001551152abbv:RevolvingCreditFacilityMaturing2030Member2026-01-012026-03-310001551152us-gaap:RevolvingCreditFacilityMember2025-12-310001551152us-gaap:RevolvingCreditFacilityMember2026-03-310001551152us-gaap:PensionPlansDefinedBenefitMember2026-01-012026-03-310001551152us-gaap:PensionPlansDefinedBenefitMember2025-01-012025-03-310001551152us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2026-01-012026-03-310001551152us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2025-01-012025-03-310001551152us-gaap:CostOfSalesMember2026-01-012026-03-310001551152us-gaap:CostOfSalesMember2025-01-012025-03-310001551152us-gaap:ResearchAndDevelopmentExpenseMember2026-01-012026-03-310001551152us-gaap:ResearchAndDevelopmentExpenseMember2025-01-012025-03-310001551152us-gaap:SellingGeneralAndAdministrativeExpensesMember2026-01-012026-03-310001551152us-gaap:SellingGeneralAndAdministrativeExpensesMember2025-01-012025-03-310001551152us-gaap:EmployeeStockOptionMember2026-01-012026-03-310001551152us-gaap:EmployeeStockOptionMember2026-03-310001551152abbv:RestrictedStockUnitsAndPerformanceSharesMember2026-01-012026-03-310001551152abbv:RestrictedStockUnitsAndPerformanceSharesMember2026-03-3100015511522025-10-012025-12-3100015511522025-07-012025-09-3000015511522025-04-012025-06-300001551152abbv:February2023StockRepurchaseAuthorizationMember2026-01-012026-03-310001551152abbv:February2023StockRepurchaseAuthorizationMember2025-01-012025-03-310001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-12-310001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2025-12-310001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-12-310001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2025-12-310001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2025-12-310001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2026-01-012026-03-310001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2026-01-012026-03-310001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2026-01-012026-03-310001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2026-01-012026-03-310001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2026-01-012026-03-310001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2026-03-310001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2026-03-310001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2026-03-310001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2026-03-310001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2026-03-310001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-12-310001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2024-12-310001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-12-310001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2024-12-310001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2024-12-310001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-310001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2025-01-012025-03-310001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-310001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2025-01-012025-03-310001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-310001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-03-310001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2025-03-310001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-03-310001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2025-03-310001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2025-03-310001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:NetInvestmentHedgingMemberus-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2026-01-012026-03-310001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:NetInvestmentHedgingMemberus-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2025-01-012025-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2026-01-012026-03-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2025-01-012025-03-310001551152us-gaap:TreasuryLockMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2026-01-012026-03-310001551152us-gaap:TreasuryLockMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2025-01-012025-03-310001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2026-01-012026-03-310001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2025-01-012025-03-310001551152abbv:NiaspanMember2026-01-012026-03-310001551152abbv:PrescriptionDrugAbuseLitigationMember2026-03-310001551152abbv:PrescriptionDrugAbuseLitigationInStateCourtsMember2026-03-310001551152abbv:PrescriptionDrugAbuseLitigationBroughtByStatesCountiesCitiesAndOtherMunicipalEntitiesMember2026-03-310001551152abbv:PrescriptionDrugAbuseLitigationInStateCourtsInProcessOfBeingDismissedMember2026-03-310001551152abbv:TaxCourtPetitionMember2023-03-012023-03-310001551152abbv:ProductLiabilityALCLLitigationMember2026-03-310001551152abbv:ProductLiabilityOtherLitigationMember2026-03-310001551152abbv:ProductLiabilityALCLLitigationInStateCourtMember2026-03-310001551152abbv:ProductLiabilityOtherLitigationInStateCourtMember2026-03-310001551152abbv:ProductLiabilityALCLLitigationInOtherCountriesMember2026-03-310001551152abbv:ProductLiabilityOtherLitigationInOtherCountriesMember2026-03-310001551152abbv:SKYRIZIMembercountry:USabbv:ImmunologyMember2026-01-012026-03-310001551152abbv:SKYRIZIMembercountry:USabbv:ImmunologyMember2025-01-012025-03-310001551152abbv:SKYRIZIMemberus-gaap:NonUsMemberabbv:ImmunologyMember2026-01-012026-03-310001551152abbv:SKYRIZIMemberus-gaap:NonUsMemberabbv:ImmunologyMember2025-01-012025-03-310001551152abbv:ImmunologyMemberabbv:SKYRIZIMember2026-01-012026-03-310001551152abbv:ImmunologyMemberabbv:SKYRIZIMember2025-01-012025-03-310001551152abbv:RINVOQMembercountry:USabbv:ImmunologyMember2026-01-012026-03-310001551152abbv:RINVOQMembercountry:USabbv:ImmunologyMember2025-01-012025-03-310001551152abbv:RINVOQMemberus-gaap:NonUsMemberabbv:ImmunologyMember2026-01-012026-03-310001551152abbv:RINVOQMemberus-gaap:NonUsMemberabbv:ImmunologyMember2025-01-012025-03-310001551152abbv:ImmunologyMemberabbv:RINVOQMember2026-01-012026-03-310001551152abbv:ImmunologyMemberabbv:RINVOQMember2025-01-012025-03-310001551152abbv:HUMIRAMembercountry:USabbv:ImmunologyMember2026-01-012026-03-310001551152abbv:HUMIRAMembercountry:USabbv:ImmunologyMember2025-01-012025-03-310001551152abbv:HUMIRAMemberus-gaap:NonUsMemberabbv:ImmunologyMember2026-01-012026-03-310001551152abbv:HUMIRAMemberus-gaap:NonUsMemberabbv:ImmunologyMember2025-01-012025-03-310001551152abbv:ImmunologyMemberabbv:HUMIRAMember2026-01-012026-03-310001551152abbv:ImmunologyMemberabbv:HUMIRAMember2025-01-012025-03-310001551152abbv:VraylarMembercountry:USabbv:NeuroscienceMember2026-01-012026-03-310001551152abbv:VraylarMembercountry:USabbv:NeuroscienceMember2025-01-012025-03-310001551152abbv:VraylarMemberus-gaap:NonUsMemberabbv:NeuroscienceMember2026-01-012026-03-310001551152abbv:VraylarMemberus-gaap:NonUsMemberabbv:NeuroscienceMember2025-01-012025-03-310001551152abbv:NeuroscienceMemberabbv:VraylarMember2026-01-012026-03-310001551152abbv:NeuroscienceMemberabbv:VraylarMember2025-01-012025-03-310001551152abbv:BotoxTherapeuticMembercountry:USabbv:NeuroscienceMember2026-01-012026-03-310001551152abbv:BotoxTherapeuticMembercountry:USabbv:NeuroscienceMember2025-01-012025-03-310001551152abbv:BotoxTherapeuticMemberus-gaap:NonUsMemberabbv:NeuroscienceMember2026-01-012026-03-310001551152abbv:BotoxTherapeuticMemberus-gaap:NonUsMemberabbv:NeuroscienceMember2025-01-012025-03-310001551152abbv:NeuroscienceMemberabbv:BotoxTherapeuticMember2026-01-012026-03-310001551152abbv:NeuroscienceMemberabbv:BotoxTherapeuticMember2025-01-012025-03-310001551152abbv:UbrelvyMembercountry:USabbv:NeuroscienceMember2026-01-012026-03-310001551152abbv:UbrelvyMembercountry:USabbv:NeuroscienceMember2025-01-012025-03-310001551152abbv:UbrelvyMemberus-gaap:NonUsMemberabbv:NeuroscienceMember2026-01-012026-03-310001551152abbv:UbrelvyMemberus-gaap:NonUsMemberabbv:NeuroscienceMember2025-01-012025-03-310001551152abbv:NeuroscienceMemberabbv:UbrelvyMember2026-01-012026-03-310001551152abbv:NeuroscienceMemberabbv:UbrelvyMember2025-01-012025-03-310001551152abbv:QuliptaMembercountry:USabbv:NeuroscienceMember2026-01-012026-03-310001551152abbv:QuliptaMembercountry:USabbv:NeuroscienceMember2025-01-012025-03-310001551152abbv:QuliptaMemberus-gaap:NonUsMemberabbv:NeuroscienceMember2026-01-012026-03-310001551152abbv:QuliptaMemberus-gaap:NonUsMemberabbv:NeuroscienceMember2025-01-012025-03-310001551152abbv:NeuroscienceMemberabbv:QuliptaMember2026-01-012026-03-310001551152abbv:NeuroscienceMemberabbv:QuliptaMember2025-01-012025-03-310001551152abbv:VyalevMembercountry:USabbv:NeuroscienceMember2026-01-012026-03-310001551152abbv:VyalevMembercountry:USabbv:NeuroscienceMember2025-01-012025-03-310001551152abbv:VyalevMemberus-gaap:NonUsMemberabbv:NeuroscienceMember2026-01-012026-03-310001551152abbv:VyalevMemberus-gaap:NonUsMemberabbv:NeuroscienceMember2025-01-012025-03-310001551152abbv:NeuroscienceMemberabbv:VyalevMember2026-01-012026-03-310001551152abbv:NeuroscienceMemberabbv:VyalevMember2025-01-012025-03-310001551152abbv:OtherNeuroscienceMembercountry:USabbv:NeuroscienceMember2026-01-012026-03-310001551152abbv:OtherNeuroscienceMembercountry:USabbv:NeuroscienceMember2025-01-012025-03-310001551152abbv:OtherNeuroscienceMemberus-gaap:NonUsMemberabbv:NeuroscienceMember2026-01-012026-03-310001551152abbv:OtherNeuroscienceMemberus-gaap:NonUsMemberabbv:NeuroscienceMember2025-01-012025-03-310001551152abbv:NeuroscienceMemberabbv:OtherNeuroscienceMember2026-01-012026-03-310001551152abbv:NeuroscienceMemberabbv:OtherNeuroscienceMember2025-01-012025-03-310001551152abbv:VENCLEXTAMembercountry:USabbv:OncologyMember2026-01-012026-03-310001551152abbv:VENCLEXTAMembercountry:USabbv:OncologyMember2025-01-012025-03-310001551152abbv:VENCLEXTAMemberus-gaap:NonUsMemberabbv:OncologyMember2026-01-012026-03-310001551152abbv:VENCLEXTAMemberus-gaap:NonUsMemberabbv:OncologyMember2025-01-012025-03-310001551152abbv:OncologyMemberabbv:VENCLEXTAMember2026-01-012026-03-310001551152abbv:OncologyMemberabbv:VENCLEXTAMember2025-01-012025-03-310001551152abbv:ImbruvicaMembercountry:USabbv:OncologyMember2026-01-012026-03-310001551152abbv:ImbruvicaMembercountry:USabbv:OncologyMember2025-01-012025-03-310001551152abbv:ImbruvicaMemberus-gaap:NonUsMemberabbv:OncologyMember2026-01-012026-03-310001551152abbv:ImbruvicaMemberus-gaap:NonUsMemberabbv:OncologyMember2025-01-012025-03-310001551152abbv:OncologyMemberabbv:ImbruvicaMember2026-01-012026-03-310001551152abbv:OncologyMemberabbv:ImbruvicaMember2025-01-012025-03-310001551152abbv:ElahereMembercountry:USabbv:OncologyMember2026-01-012026-03-310001551152abbv:ElahereMembercountry:USabbv:OncologyMember2025-01-012025-03-310001551152abbv:ElahereMemberus-gaap:NonUsMemberabbv:OncologyMember2026-01-012026-03-310001551152abbv:ElahereMemberus-gaap:NonUsMemberabbv:OncologyMember2025-01-012025-03-310001551152abbv:OncologyMemberabbv:ElahereMember2026-01-012026-03-310001551152abbv:OncologyMemberabbv:ElahereMember2025-01-012025-03-310001551152abbv:EpkinlyMembercountry:USabbv:OncologyMember2026-01-012026-03-310001551152abbv:EpkinlyMembercountry:USabbv:OncologyMember2025-01-012025-03-310001551152abbv:EpkinlyMemberus-gaap:NonUsMemberabbv:OncologyMember2026-01-012026-03-310001551152abbv:EpkinlyMemberus-gaap:NonUsMemberabbv:OncologyMember2025-01-012025-03-310001551152abbv:OncologyMemberabbv:EpkinlyMember2026-01-012026-03-310001551152abbv:OncologyMemberabbv:EpkinlyMember2025-01-012025-03-310001551152abbv:OtherOncologyMembercountry:USabbv:OncologyMember2026-01-012026-03-310001551152abbv:OtherOncologyMembercountry:USabbv:OncologyMember2025-01-012025-03-310001551152abbv:BotoxCosmeticMembercountry:USabbv:AestheticsMember2026-01-012026-03-310001551152abbv:BotoxCosmeticMembercountry:USabbv:AestheticsMember2025-01-012025-03-310001551152abbv:BotoxCosmeticMemberus-gaap:NonUsMemberabbv:AestheticsMember2026-01-012026-03-310001551152abbv:BotoxCosmeticMemberus-gaap:NonUsMemberabbv:AestheticsMember2025-01-012025-03-310001551152abbv:AestheticsMemberabbv:BotoxCosmeticMember2026-01-012026-03-310001551152abbv:AestheticsMemberabbv:BotoxCosmeticMember2025-01-012025-03-310001551152abbv:JuvedermCollectionMembercountry:USabbv:AestheticsMember2026-01-012026-03-310001551152abbv:JuvedermCollectionMembercountry:USabbv:AestheticsMember2025-01-012025-03-310001551152abbv:JuvedermCollectionMemberus-gaap:NonUsMemberabbv:AestheticsMember2026-01-012026-03-310001551152abbv:JuvedermCollectionMemberus-gaap:NonUsMemberabbv:AestheticsMember2025-01-012025-03-310001551152abbv:AestheticsMemberabbv:JuvedermCollectionMember2026-01-012026-03-310001551152abbv:AestheticsMemberabbv:JuvedermCollectionMember2025-01-012025-03-310001551152abbv:OtherAestheticsMembercountry:USabbv:AestheticsMember2026-01-012026-03-310001551152abbv:OtherAestheticsMembercountry:USabbv:AestheticsMember2025-01-012025-03-310001551152abbv:OtherAestheticsMemberus-gaap:NonUsMemberabbv:AestheticsMember2026-01-012026-03-310001551152abbv:OtherAestheticsMemberus-gaap:NonUsMemberabbv:AestheticsMember2025-01-012025-03-310001551152abbv:AestheticsMemberabbv:OtherAestheticsMember2026-01-012026-03-310001551152abbv:AestheticsMemberabbv:OtherAestheticsMember2025-01-012025-03-310001551152abbv:MAVYRETMembercountry:USabbv:OtherKeyProductsMember2026-01-012026-03-310001551152abbv:MAVYRETMembercountry:USabbv:OtherKeyProductsMember2025-01-012025-03-310001551152abbv:MAVYRETMemberus-gaap:NonUsMemberabbv:OtherKeyProductsMember2026-01-012026-03-310001551152abbv:MAVYRETMemberus-gaap:NonUsMemberabbv:OtherKeyProductsMember2025-01-012025-03-310001551152abbv:OtherKeyProductsMemberabbv:MAVYRETMember2026-01-012026-03-310001551152abbv:OtherKeyProductsMemberabbv:MAVYRETMember2025-01-012025-03-310001551152abbv:CreonMembercountry:USabbv:OtherKeyProductsMember2026-01-012026-03-310001551152abbv:CreonMembercountry:USabbv:OtherKeyProductsMember2025-01-012025-03-310001551152abbv:LinzessConstellaMembercountry:USabbv:OtherKeyProductsMember2026-01-012026-03-310001551152abbv:LinzessConstellaMembercountry:USabbv:OtherKeyProductsMember2025-01-012025-03-310001551152abbv:LinzessConstellaMemberus-gaap:NonUsMemberabbv:OtherKeyProductsMember2026-01-012026-03-310001551152abbv:LinzessConstellaMemberus-gaap:NonUsMemberabbv:OtherKeyProductsMember2025-01-012025-03-310001551152abbv:OtherKeyProductsMemberabbv:LinzessConstellaMember2026-01-012026-03-310001551152abbv:OtherKeyProductsMemberabbv:LinzessConstellaMember2025-01-012025-03-310001551152abbv:OtherProductsMember2026-01-012026-03-310001551152abbv:OtherProductsMember2025-01-012025-03-31\n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWASHINGTON, D.C. 20549\n\nFORM 10-Q\n\n(Mark One)\n\n☒    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\nFor the quarterly period ended March 31, 2026\n\nOR\n\n☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\nFor the transition period from                                    to                                   \n\nCommission File Number: 001-35565\n\nAbbVie Inc.\n\n(Exact name of registrant as specified in its charter)\n\nDelaware\n\n32-0375147\n\n(State or other jurisdiction of incorporation or organization)\n(I.R.S. employer identification number)\n\n1 North Waukegan Road\n\nNorth Chicago, Illinois 60064-6400\n\nTelephone: (847) 932-7900\n\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.        Yes ☒ No ☐\n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).        Yes ☒ No ☐\n\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and \"emerging growth company\" in Rule 12b-2 of the Exchange Act.\n\nLarge Accelerated Filer\n☒Accelerated Filer☐\n\nNon-Accelerated Filer☐Smaller reporting company☐\n\nEmerging growth company☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).        Yes ☐ No ☒\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each classTrading Symbol(s)Name of each exchange on which registered\n\nCommon Stock, par value $0.01 per shareABBVNew York Stock Exchange\n\nNYSE Texas\n\n0.750% Senior Notes due 2027ABBV27New York Stock Exchange\n\n2.125% Senior Notes due 2028ABBV28New York Stock Exchange\n\n2.625% Senior Notes due 2028ABBV28BNew York Stock Exchange\n\n2.125% Senior Notes due 2029ABBV29New York Stock Exchange\n\n1.250% Senior Notes due 2031ABBV31New York Stock Exchange\n\nAs of April 28, 2026, AbbVie Inc. had 1,766,792,821 shares of common stock at $0.01 par value outstanding.\n\nAbbVie Inc. and Subsidiaries\n\nTable of Contents\n\n[PART I.](#ifeb795018bc64289b20b13fb215146ea_10)\n\n[FINANCIAL INFORMATION](#ifeb795018bc64289b20b13fb215146ea_10)\n\nPage\n\n[Item 1.](#ifeb795018bc64289b20b13fb215146ea_13)\n\n[FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA](#ifeb795018bc64289b20b13fb215146ea_13)\n\n[1](#ifeb795018bc64289b20b13fb215146ea_13)\n\n[Item 2.](#ifeb795018bc64289b20b13fb215146ea_97)\n\n[MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS](#ifeb795018bc64289b20b13fb215146ea_97)\n\n[22](#ifeb795018bc64289b20b13fb215146ea_97)\n\n[Item 3.](#ifeb795018bc64289b20b13fb215146ea_139)\n\n[QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK](#ifeb795018bc64289b20b13fb215146ea_139)\n\n[31](#ifeb795018bc64289b20b13fb215146ea_139)\n\n[Item 4.](#ifeb795018bc64289b20b13fb215146ea_142)\n\n[CONTROLS AND PROCEDURES](#ifeb795018bc64289b20b13fb215146ea_142)\n\n[31](#ifeb795018bc64289b20b13fb215146ea_142)\n\n[PART II.](#ifeb795018bc64289b20b13fb215146ea_145)\n\n[OTHER INFORMATION](#ifeb795018bc64289b20b13fb215146ea_145)\n\n[Item 1.](#ifeb795018bc64289b20b13fb215146ea_148)\n\n[LEGAL PROCEEDINGS](#ifeb795018bc64289b20b13fb215146ea_148)\n\n[32](#ifeb795018bc64289b20b13fb215146ea_148)\n\n[Item 2.](#ifeb795018bc64289b20b13fb215146ea_154)\n\n[UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS](#ifeb795018bc64289b20b13fb215146ea_154)\n\n[32](#ifeb795018bc64289b20b13fb215146ea_154)\n\n[Item 5.](#ifeb795018bc64289b20b13fb215146ea_157)\n\n[OTHER ITEMS](#ifeb795018bc64289b20b13fb215146ea_157)\n\n[32](#ifeb795018bc64289b20b13fb215146ea_157)\n\n[Item 6.](#ifeb795018bc64289b20b13fb215146ea_160)\n\n[EXHIBITS](#ifeb795018bc64289b20b13fb215146ea_160)\n\n[33](#ifeb795018bc64289b20b13fb215146ea_160)\n\nPART I. FINANCIAL INFORMATION"}